Dare Bioscience

DAREPre-clinical

Dare Bioscience, Inc. is a mission-driven company committed to addressing significant unmet needs in women's health through the development of novel, localized therapeutics. Its strategy centers on proprietary technology platforms designed to deliver drugs directly to the site of action, aiming to improve efficacy and safety profiles. The company's lead assets target large market opportunities in contraception and bacterial vaginosis, positioning it in a high-need, underserved therapeutic area. As a public entity, Dare faces the dual challenge of executing on clinical milestones while navigating the capital-intensive biotech landscape.

Market Cap

$254.0M

Employees

11-50

Focus

Biotech

DARE · Stock Price

USD 18.84+9.24 (+96.25%)

Historical price data

AI Company Overview

Technology Platform

Proprietary intravaginal ring (IVR) technology for sustained drug delivery and a bioadhesive hydrogel platform for localized, on-demand delivery of therapeutics to vaginal tissue.

Funding History

Total raised: $62M

PIPE$30MUndisclosedNov 15, 2020

Series B$20MUndisclosedJul 15, 2016

Series A$12MUndisclosedFeb 15, 2014

Opportunities

Dare has significant opportunities in the large, underserved women's health market.

Success with DARE-BV1 could establish a beachhead and generate revenue to fund other programs.

The user-controlled contraceptive DARE-LARC1 addresses a major gap in the LARC market.

The company's platform technologies are also potentially applicable to other indications, enabling pipeline expansion.

Risk Factors

Key risks include clinical trial failure, especially for the pivotal Phase 3 DARE-BV1 trial; severe liquidity constraints and dependence on dilutive financing; regulatory hurdles; intense competition from established products; and the challenge of securing a favorable partnership for commercialization.

Competitive Landscape

Dare competes against large pharma (Bayer, Organon) in contraception and generic antibiotics in BV. Its differentiation lies in its novel delivery platforms designed for localized action, user control, and convenience. However, it must overcome high commercial barriers and prove superior efficacy or tolerability to gain market share.